Oral leukoplakias with different degrees of dysplasia: Comparative study of hMLH1, p53, and AgNOR

Journal of Oral Pathology and Medicine

Volumn 40, Issue 4, 2011, Pages 305-311

  Caldeira, Patrícia Carlos ^a   Aguiar, Maria Cássia Ferreira ^a   Mesquita, Ricardo Alves ^a   do Carmo, Maria Auxiliadora Vieira ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

AgNOR; Human MLH1 protein; Immunohistochemistry; Oral leukoplakia; P53 protein

Indexed keywords

PROTEIN MLH1; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME NOR; DISEASE SEVERITY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; ORAL DYSPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SILVER NUCLEOLAR ORGANIZER REGION TECHNIQUE; TECHNIQUE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, NUCLEAR; CASE-CONTROL STUDIES; CELL PROLIFERATION; DNA MISMATCH REPAIR; FEMALE; HUMANS; KERATINOCYTES; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NUCLEAR PROTEINS; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952855697     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.01000.x     Document Type: Article

References (32)

1. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 2009; 15: 388-99.
2. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37: 1-10.
3. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45: 317-23.
4. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
5. Tanić N, Tanić N, Milasin J, Vukadinović M, Dimitrijević B. Genomic instability and tumor-specific DNA alterations in oral leukoplakias. Eur J Oral Sci 2009; 117: 231-7.
6. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999; 9: 89-96.
7. Jun SH, Kim TG, Ban C. DNA mismatch repair system. Classical and fresh roles. FEBS J 2006; 273: 1609-19.
8. Paraf F, Gilquin M, Longy M, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001; 39: 250-8.
9. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003; 138: 560-70.
10. Ha PK, Pilkington TA, Westra WH, Sciubba J, Sidransky D, Califano JA. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 2002; 102: 615-7.
11. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007; 109: 703-12.
12. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 2004; 445: 431-41.
13. Fernandes AM, Ramos-Jorge ML, Cardoso SV, Loyola AM, Mesquita RA, Aguiar MC. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. J Oral Pathol Med 2008; 37: 543-8.
14. Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Annu Rev Biochem 2008; 77: 557-82.
15. Kurokawa H, Matsumoto S, Murata T, et al. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 2003; 32: 513-21.
16. Cruz I, Napier SS, van der Waal I, et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 2002; 55: 98-104.
17. Ogmundsdóttir HM, Björnsson J, Holbrook WP. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. J Oral Pathol Med 2009; 38: 565-71.
18. Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002; 511: 145-78.
19. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2002; 126: 548-53.
20. Zabkiewicz J, Clarke AR. DNA damage-induced apoptosis: insights from the mouse. Biochim Biophys Acta 2004; 1705: 17-25.
21. O'brien V, Brown R. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 2006; 27: 682-92.
22. Derenzini M, Pasquinelli G, O'donohue M-F, Ploton D, Thiry M. Structural and functional organization of ribosomal genes within the mammalian cell nucleolus. J Histochem Cytochem 2006; 54: 131-45.
23. Chattopadhyay A, Chawda JG, Doshi JJ. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma. Int J Oral Maxillofac Surg 1994; 23: 374-7.
24. Chattopadhyay A, Ray JG. AgNOR cut-point to distinguish mild and moderate epithelial dysplasia. J Oral Pathol Med 2008; 37: 78-82.
25. World Health Organization. Tumours of the oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, Sedransky D, eds. Pathology & Genetics. Head Neck Tumors. Lyon: IARC Press, 2005; 177-9.
26. Fernandes AM, De Souza VR, Springer CR, et al. Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. Anticancer Res 2007; 27: 2433-7.
27. Fan GK, Chen J, Ping F, Geng Y. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 2006; 42: 147-53.
28. Kerdpon D, Rich AM, Reade PC. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 1997; 3: 86-92.
29. Cruz IB, Snijders PJ, Meijer CJ, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998; 184: 360-8.
30. Murti PR, Warnakulasuriya KA, Johnson NW, et al. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998; 27: 191-6.
31. Elangovan T, Mani NJ, Malathi N. Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment. Indian J Dent Res 2008; 19: 141-6.
32. Cabrini RL, Schwint AE, Mendez A, Femopase F, Lanfranchi H, Itoiz ME. Morphometric study of nucleolar organizer regions in human oral normal mucosa, papilloma and squamous cell carcinoma. J Oral Pathol Med 1992; 21: 275-9.